

IPO momentum is exceptionally strong: through July 10, operating companies raised $140B in IPO proceeds, with 91% of issuance occurring on Nasdaq. In just over six months, 2026 has nearly matched 2021’s full-year record at $141B, signaling a substantial risk-on capital rotation into new listings.
The first-order takeaway is not just that the IPO calendar is open, but that exchange economics are getting a rare two-step boost: more listings today, and a larger installed base of issuers to monetize tomorrow through data, connectivity, and index inclusion. For NDAQ, the most valuable part of this wave is not the headline capital raised; it is the option value on a sustained pipeline that can lift recurring revenue quality faster than the market is likely modeling.
The second-order dynamic is competitive pressure inside market structure. When issuance is this active, bankers and trading venues fight harder on economics, so the incremental margin capture for the exchange can be less than the market assumes. At the same time, a healthy IPO market can actually be a headwind for some small-cap incumbents as fresh supply and benchmark rebalancing redirect investor attention and capital toward new issues, keeping relative performance of IWM-style baskets mixed even if risk appetite looks strong.
The main risk is that IPO activity is a cyclical liquidity phenomenon masquerading as a structural one. If rates back up, volatility rises, or the first post-lockup cohort trades poorly, the window can close quickly and the current run-rate will look like a front-loaded pull-forward rather than a new regime. The contrarian angle is that consensus may be overpaying for a one-time issuance burst while underestimating how much of NDAQ’s upside actually comes from sustained secondary trading and data revenues, which need the broader equity tape to remain constructive for months, not weeks.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
strongly positive
Sentiment Score
0.45
Ticker Sentiment